DIMAPUR: Nagaland has not yet received COVID-19 vaccine doses to inoculate the people in the age group of 18 to 44 years in the State. Vaccination for this age group was scheduled to start from May 1.
Nagaland health and family welfare department today said the vaccination of the age group of 18 to 44 years will begin only when the state receives the required doses of vaccine from the manufacturer.
It said, the state has recently received a letter from Serum Institute India, manufacturer of Covishield vaccine, stating that they will supply 36,580 doses of Covishield vaccine in the first batch.
The department said the state government is in the process to procure another four lakh doses to begin its third phase of COVID-19 vaccination drive.
Though registration in the selfregistration.cowin.gov.in and AarogyaSetu App will continue, booking for vaccination will start only when the state announces the date for commencement of vaccination for the third phase for this age group, the department said.
Meanwhile, in partial modification of the Nagaland State Disaster Management Authority (NSDMA) order dated April 21, 2021, the state level war room on COVID-19 has been restarted with the chief secretary and chairperson of the state executive committee, NSDMA, as the chairman and members from the key line departments.
The state level control room will function at the chief secretary's conference hall at Nagaland Civil Secretariat in Kohima and the required logistical arrangements will be supported by the NSDMA.
The state level war room will ensure unity of command and control in the fight against COVID-19 in the State.
It will further ensure sharing of all relevant information on real time basis so that prompt and effective action is taken by the departments/officials/agencies concerned for preventing the spread of COVID-19 as well as for making interventions, whenever required, for strengthening the health infrastructure and the clinical management of the COVID-19 patients.
Copyright©2023 Living Media India Limited. For reprint rights: Syndications Today